- Pfizer (New York, NY)
- … trial(s) in support of the development strategy for programs within the Late - Stage Oncology portfolio. **Position Responsibilities** + Maintains current ... scientific and clinical knowledge in the specific therapeutic and disease area(s)... Research experience in the Phase 3/pivotal space in Oncology , ideally on the side of the sponsor. +… more
- Pfizer (New York, NY)
- **ROLE SUMMARY:** The Senior Manager, Oncology Early Stage Clinical Scientist will work collaboratively with the Global Development Lead (and members of the ... team) to establish, lead, coordinate, and execute the early oncology clinical development plan(s) for one or...the GDL. + May support the transition early development clinical programs into late stage … more
- Regeneron Pharmaceuticals (Tarrytown, NY)
- …design and execute research and development programs for early and/or late stage assets. This role may be clinical subject matter expert for assigned ... and conduct issues. This role reports into the Senior Medical Director- Oncology Clinical Development, Clinical Sciences and is expected to have proficient… more
- Regeneron Pharmaceuticals (Tarrytown, NY)
- …and related conditions, Cardiovascular, Renal, and Specialty Medicines, which currently encompass 12 clinical stage assets. The VP, CVRM TAL will also partner ... areas on areas and assets of intersection -Inflammation and Immunology, Neuroscience, Oncology etc. This is a critical strategic and execution role that will… more
- Regeneron Pharmaceuticals (Armonk, NY)
- …implementation of clinical biomarker strategies across key programs in early and late stage drug development. Further, this role is responsible for providing ... in pharmaceutical or biotech industry, including a minimum of 5 years in oncology clinical drug development is required. Does this sound like you? Apply now to… more
- Sumitomo Pharma (New York, NY)
- …products in the US, Canada, and Europe, and a diverse pipeline of early- to late - stage assets, we aim to accelerate discovery, research, and development to bring ... products in the US, Canada, and Europe, a diverse pipeline of early- to late - stage assets, and in-house advanced technology capabilities, we aim to accelerate… more
- Regeneron Pharmaceuticals (Armonk, NY)
- …implementation of clinical biomarker strategies across key programs in early and late stage drug development. Further, this role is responsible for providing ... phases (leading to candidate molecule selection) and to further clinical development in Oncology . + Accountability for...selection) and to further clinical development in Oncology . + Accountability for ensuring that biomarker assays are… more
- Regeneron Pharmaceuticals (Armonk, NY)
- …with partners/IVD Sponsors and central testing laboratories in support of early and late - stage programs within our oncology and non- oncology ... filing) + Be viewed as a subject matter expert in oncology and able to effectively communicate with clinical study teams on program direction + Help define CDx… more
- Regeneron Pharmaceuticals (Armonk, NY)
- …collaboration with partners/IVD Sponsors and central testing laboratories to support early and late - stage programs within our oncology pipeline. **As a ... + Be viewed as a subject matter expert in oncology and able to effectively communicate with clinical study teams on program direction + Able to define… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (New York, NY)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more